Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v16.i1-2.60
pages 47-63

TAM Receptors in Leukemia: Expression, Signaling, and Therapeutic Implications

Luis Brandao
Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado
Justine Migdall-Wilson
Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado
Kristen Eisenman
Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado
Douglas K. Graham
Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado

RESUMO

In the past 30 years there has been remarkable progress in the treatment of leukemia and lymphoma. However, current treatments are largely ineffective against relapsed leukemia and, in the case of pediatric patients, are often associated with severe long-term toxicities. Thus, there continues to be a critical need for the development of effective biologically targeted therapies. The TAM family of receptor tyrosine kinases−Tyro3, Axl, and Mer−plays an important role in normal hematopoiesis, including natural killer cell maturation, macrophage function, and platelet activation and signaling. Furthermore, TAM receptor activation leads to upregulation of pro-survival and proliferation signaling pathways, and aberrant TAM receptor expression contributes to cancer development, including myeloid and lymphoid leukemia. This review summarizes the role of TAM receptors in leukemia. We outline TAM receptor expression patterns in different forms of leukemia, describe potential mechanisms leading to their overexpression, and delineate the signaling pathways downstream of receptor activation that have been implicated in leukemogenesis. Finally, we discuss the current research focused on inhibitors against these receptors in an effort to develop new therapeutic strategies for leukemia.


Articles with similar content:

RUNX Expression and Function in Human B Cells
Critical Reviews™ in Eukaryotic Gene Expression, Vol.16, 2006, issue 1
Hannah J. Whiteman, Paul J. Farrell
The Nuclear Matrix as a Target for Viral and Cellular Oncogenes
Critical Reviews™ in Eukaryotic Gene Expression, Vol.10, 2000, issue 1
Wolfgang Deppert
Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Carlos L. Arteaga, Brent N. Rexer
The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases
Critical Reviews™ in Immunology, Vol.36, 2016, issue 6
Alyssa Kearly, Lee Ann Garrett-Sinha, Anne B. Satterthwaite
T- and B-Cell Abnormalities in Systemic Lupus Erythematosus
Critical Reviews™ in Immunology, Vol.25, 2005, issue 2
Gyorgy Nagy, Agnes Koncz, Andras Perl